DaVita

company

About

DaVita is a provider focused on transforming care delivery to improve quality of life for patients globally.

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$750M
Industries
Health Care
Founded date
Jan 1, 1979
Number Of Employee
10001 - max
Operating Status
Active
Stock Symbol
nyse:DVA
Legal Name
Davita, Inc.

DaVita is a provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of June 30, 2012, DaVita operated or provided administrative services at 1,884 outpatient dialysis centers located in the United States, serving approximately 149,000 patients. The company also operated 19 outpatient dialysis centers located in four countries outside the United States. DaVita supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$750M
DaVita has raised a total of $750M in funding over 2 rounds. Their latest funding was raised on Feb 24, 2021 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 24, 2021 Post-IPO Debt $750M Detail
Nov 10, 1995 IPO Detail

Investments

Number of Investments
Number of Lead Investments
2
1
DaVita has made 2 investments. Their most recent investment was on Apr 11, 2022, when Rockwell Medical raised $15M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 11, 2022 Rockwell Medical
Post-IPO Equity $15M Biopharma Yes
Oct 30, 2013 CVRx
Series F $12M Biotechnology

Employee Profiles

Number of Employee Profiles
22
DaVita has 22 current employee profiles, including Executive Brannan Schell
Executive
Executive
Executive
Executive
Executive

Exits

DaVita has had 2 exits. DaVita most notable exits include CVRx ,   Rockwell Medical

Date Company Name Exit Type Industry
Jun 29, 2021 CVRx IPO Biotechnology Detail
Jan 27, 1998 Rockwell Medical IPO Biopharma Detail

Acquisition

DaVita has acquired 6 organizations. Their most recent acquisition was Gambro Healthcare on Dec 7, 2004. They acquired Gambro Healthcare for 0.

Date Company Name
Industry Acquisition Type Price
Health Care acquisition Detail
Biotechnology Detail
Association acquisition Detail
May 8, 2017 Purity Dialysis
Health Care acquisition Detail
Health Care acquisition Detail